Vincent A. DeLeo, MD, Chairman, Department of Dermatology, St. Luke’s-Roosevelt Hospital Center, New York, New York, and Beth Israel Medical Center, New York, discusses the US Food and Drug Administration’s Proposed Rule on sunscreen drug products for over-the-counter human use. The document addresses the proper development, testing, and labeling of sunscreen products. Dermatologists will be at the forefront of educating and helping consumers understand the meaning of the new labeling.

The original editorials were featured in Cutis®, which provided an overview and discussion of the Proposed Rule.

Resources:
DeLeo VA. Proposed FDA rule on sunscreens, part 1: a new label [editorial].Cutis. 2008;81:460-462.

DeLeo VA. Proposed FDA rule on sunscreens, part 2: UVA [editorial]. Cutis. 2008;82:17-19.